Skip to main content
. 2009 Jun 17;16(1):55. doi: 10.1186/1423-0127-16-55

Figure 2.

Figure 2

Cdk5 inhibitors dose-dependently inhibit peptide substrate phosphorylation in a SPA assay. A. Roscovitine dose-dependently inhibits substrate phosphorylation with IC50 280 nM. B. WL compound dose-dependently inhibits substrate phosphorylation with IC50 45 nM. C. AZ compound dose-dependently inhibits substrate phosphorylation with IC50 355 nM. Structures of these compounds are shown next to their respective inhibition curves.